Standardized Concentrations Needed For Pediatric Cough/Cold Safety – CDER
This article was originally published in The Tan Sheet
Executive Summary
Standardizing the concentrations of ingredients in OTC cough/cold products would help reduce confusion between formulations for children and those for infants, FDA's Center for Drug Evaluation and Research recommends
You may also be interested in...
Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned
FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.